Stat3 role in the protective effect of FXR agonists in parenteral nutrition-associated cholestasis
Background and Aims:. Parenteral nutrition (PN) in patients with intestinal failure can lead to cholestasis (PNAC). In a PNAC mouse model, farnesoid X receptor (FXR) agonist (GW4064) treatment alleviated IL-1β-dependent cholestatic liver injury. The objective of this study was to determine whether t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Health/LWW
2023-03-01
|
Series: | Hepatology Communications |
Online Access: | http://journals.lww.com/10.1097/HC9.0000000000000056 |